News

In a big victory for patients who depend on prescription drugs, a federal judge struck down a 2021 HHS rule that allowed health insurers to not count drug manufacturer copay assistance towards a patient's out-of-pocket costs.

The mental health of U.S. employees is finally on the rise, nearly three years after the pandemic.

All the manufacturers of the first 10 prescription drugs selected for Medicare price negotiations agreed to participate by the Oct. 1 deadline, however, the process could be complicated by lawsuits filed by all of these drugmakers.

Nurses, medical technicians, pharmacists and support staff began striking Wednesday morning, which shows how tension between health-care companies and burned-out workers has escalated since the onset of the pandemic.

33% of employers find it a challenge to remain compliant with Family and Medical Leave (FMLA) and Americans with Disabilities Act Amendments Act (ADAAA).

The agreements settle whistleblower lawsuits that the Department of Justice joined, alleging the insurer submitted false diagnosis codes to artificially inflate its payments from the Medicare Advantage program.

Findings from annual study also reinforce demand for whole-person care and equitable access.

Aggregate stop-loss coverage is most prevalent in conjunction with individual stop-loss deductibles of $250,000 or less.